Editorial Expression of Concern: Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN (Pharm Res, (2011), 28, (3091-3100), 10.1007/s11095-011-0570-y);Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN

Pharmaceutical Research

Volumn 28, Issue 12, 2011, Pages 3091-3100

  Liang, Zhongxing ^a,b   Li, Yuhua ^b   Huang, Ke ^a   Wagar, Nicholas ^b   Shim, Hyunsuk ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

breast cancer; microRNA; multidrug resistance; PTEN

Indexed keywords

ETOPOSIDE; LOCKED NUCLEIC ACID ANTIMIR 19A; MICRORNA; MIRNA 19; MITOXANTRONE; NUCLEIC ACID; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 83555173262     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-022-03417-5     Document Type: Erratum

References (40)

1. MM Gottesman T Fojo SE Bates 2002 Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2 1 48 58 11902585 10.1038/nrc706 1:CAS:528:DC%2BD38XhvF2jtL8%3D (Pubitemid 37328807)
2. G Szakacs JK Paterson JA Ludwig C Booth-Genthe MM Gottesman 2006 Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 3 219 234 16518375 10.1038/nrd1984 1:CAS:528:DC%2BD28XhvFOlsr8%3D (Pubitemid 43336035)
3. JT Lee Jr LS Steelman JA McCubrey 2004 Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells Cancer Res 64 22 8397 8404 15548710 10.1158/0008-5472.CAN-04-1612 1:CAS:528: DC%2BD2cXpvVGksrk%3D (Pubitemid 39491779)
4. M Filipits G Pohl M Rudas O Dietze S Lax R Grill, et al. 2005 Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group J Clin Oncol 23 6 1161 1168 15718312 10.1200/JCO.2005.03.033 1:CAS:528:DC%2BD2MXitl2gurw%3D (Pubitemid 46202272)
5. LA Doyle DD Ross 2003 Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene 22 47 7340 7358 14576842 10.1038/sj.onc.1206938 (Pubitemid 37487163)
6. CM Croce GA Calin 2005 miRNAs, cancer, and stem cell division Cell 122 1 6 7 16009126 10.1016/j.cell.2005.06.036 1:CAS:528:DC%2BD2MXmsFeitb8%3D (Pubitemid 40977933)
7. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2 281 297 14744438 10.1016/S0092-8674(04)00045-5 1:CAS:528: DC%2BD2cXhtVals7o%3D (Pubitemid 38167318)
8. V Ambros 2001 microRNAs: tiny regulators with great potential Cell 107 7 823 826 11779458 10.1016/S0092-8674(01)00616-X 1:CAS:528:DC%2BD38XjtlKmtg%3D%3D (Pubitemid 34084973)
9. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck, et al. 2005 MicroRNA expression profiles classify human cancers Nature 435 7043 834 838 15944708 10.1038/nature03702 1:CAS:528:DC%2BD2MXkvVGgsLc%3D (Pubitemid 40839735)
10. FJ Slack JB Weidhaas 2006 MicroRNAs as a potential magic bullet in cancer Future Oncol 2 1 73 82 16556074 10.2217/14796694.2.1.73 1:CAS:528: DC%2BD28Xhs1Wku7w%3D
11. A Cimmino GA Calin M Fabbri MV Iorio M Ferracin M Shimizu, et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci U S A 102 39 13944 13949 16166262 10.1073/pnas.0506654102 1:CAS:528:DC%2BD2MXhtVOqsbjK (Pubitemid 41377683)
12. J Jiang EJ Lee Y Gusev TD Schmittgen 2005 Real-time expression profiling of microRNA precursors in human cancer cell lines Nucleic Acids Res 33 17 5394 5403 16192569 10.1093/nar/gki863 1:CAS:528:DC%2BD2MXhtFWltrrE (Pubitemid 41548806)
13. H Zhu H Wu X Liu BR Evans DJ Medina CG Liu, et al. 2008 Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem Pharmacol 76 5 582 588 18619946 10.1016/j.bcp.2008.06.007 1:CAS:528:DC%2BD1cXhtVSitbfN
14. O Kovalchuk J Filkowski J Meservy Y Ilnytskyy VP Tryndyak VF Chekhun, et al. 2008 Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol Cancer Ther 7 7 2152 2159 18645025 10.1158/1535-7163.MCT-08-0021 1:CAS:528:DC%2BD1cXoslCnsr8%3D
15. YZ Pan MEYuAM Morris 2009 MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells Mol Pharmacol 75 6 1374 1379 19270061 10.1124/mol.108.054163 1:CAS:528:DC%2BD1MXmvVWqsbs%3D
16. Z Liang H Wu J Xia Y Li Y Zhang K Huang, et al. 2010 Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1 Biochem Pharmacol 79 6 817 824 19883630 10.1016/j.bcp.2009.10.017 1:CAS:528:DC%2BC3cXnvFCruw%3D%3D
17. E Schneider JK Horton CH Yang M Nakagawa KH Cowan 1994 Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance Cancer Res 54 1 152 158 7903202 1:CAS:528: DyaK2cXht1Churw%3D (Pubitemid 24042102)
18. Z Liang T Wu H Lou X Yu RS Taichman SK Lau, et al. 2004 Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4 Cancer Res 64 12 4302 4308 15205345 10.1158/0008-5472.CAN-03-3958 1:CAS:528: DC%2BD2cXkvFWlsbs%3D (Pubitemid 38802437)
19. Z Liang J Brooks M Willard K Liang Y Yoon S Kang, et al. 2007 CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway Biochem Biophys Res Commun 359 3 716 722 17559806 10.1016/j.bbrc.2007.05.182 1:CAS:528:DC%2BD2sXmsFyktbk%3D (Pubitemid 46908803)
20. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
21. X Zhou Y Ren L Moore M Mei Y You P Xu, et al. 2010 Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status Lab Invest 90 2 144 155 20048743 10.1038/labinvest.2009.126 1:CAS:528:DC%2BC3cXht1Kqs7s%3D
22. JS Kim X Peng PK De RL Geahlen DL Durden 2002 PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac Blood 99 2 694 697 11781256 10.1182/blood.V99.2.694 1:CAS:528:DC%2BD38XmslGqsg%3D%3D (Pubitemid 34533110)
23. GA Calin CM Croce 2006 MicroRNA signatures in human cancers Nat Rev Cancer 6 11 857 866 17060945 10.1038/nrc1997 1:CAS:528:DC%2BD28XhtFWhs7fM (Pubitemid 44629897)
24. BP Lewis CB Burge DP Bartel 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 1 15 20 15652477 10.1016/j.cell.2004.12.035 1:CAS:528:DC%2BD2MXot1ChsA%3D%3D (Pubitemid 40094598)
25. A Carnero C Blanco-Aparicio O Renner W Link JF Leal 2008 The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications Curr Cancer Drug Targets 8 3 187 198 18473732 10.2174/156800908784293659 1:CAS:528:DC%2BD1cXmtFamt7g%3D (Pubitemid 351688437)
26. E Oki H Baba E Tokunaga T Nakamura N Ueda M Futatsugi, et al. 2005 Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer Int J Cancer 117 3 376 380 15900596 10.1002/ijc.21170 1:CAS:528:DC%2BD2MXhtFant7rJ (Pubitemid 41429560)
27. BH Choi CG Kim Y Lim SY Shin YH Lee 2008 Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway Cancer Lett 259 1 111 118 18006147 10.1016/j.canlet.2007.10.003 1:CAS:528:DC%2BD2sXhsVCgtL7P (Pubitemid 350235095)
28. T Takada H Suzuki Y Gotoh Y Sugiyama 2005 Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells Drug Metab Dispos 33 7 905 909 15843490 10.1124/dmd.104.003228 1:CAS:528:DC%2BD2MXlslWqs7w%3D (Pubitemid 41002770)
29. ML Si S Zhu H Wu Z Lu F Wu YY Mo 2007 miR-21-mediated tumor growth Oncogene 26 19 2799 2803 17072344 10.1038/sj.onc.1210083 1:CAS:528: DC%2BD2sXksF2rsb4%3D (Pubitemid 46663837)
30. SD Selcuklu MT Donoghue C Spillane 2009 miR-21 as a key regulator of oncogenic processes Biochem Soc Trans 37 Pt 4 918 925 19614619 10.1042/BST0370918 1:CAS:528:DC%2BD1MXovVOisrs%3D
31. S Zhu H Wu F Wu D Nie S Sheng YY Mo 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res 18 3 350 359 18270520 10.1038/cr.2008.24 1:CAS:528:DC%2BD1cXivVyjsb8%3D (Pubitemid 351333899)
32. V Olive MJ Bennett JC Walker C Ma I Jiang C Cordon-Cardo, et al. 2009 miR-19 is a key oncogenic component of mir-17-92 Genes Dev 23 24 2839 2849 20008935 10.1101/gad.1861409 1:CAS:528:DC%2BC3cXntFKn
33. L Hong M Lai M Chen C Xie R Liao YJ Kang, et al. 2010 The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence Cancer Res 70 21 8547 8557 20851997 10.1158/0008-5472.CAN-10-1938 1:CAS:528:DC%2BC3cXhtlKjtrfL
34. S Davis B Lollo S Freier C Esau 2006 Improved targeting of miRNA with antisense oligonucleotides Nucleic Acids Res 34 8 2294 2304 16690972 10.1093/nar/gkl183 1:CAS:528:DC%2BD28Xks1Smt7o%3D (Pubitemid 43985667)
35. UA Orom S Kauppinen AH Lund 2006 LNA-modified oligonucleotides mediate specific inhibition of microRNA function Gene 372 137 141 16503100 10.1016/j.gene.2005.12.031 1:CAS:528:DC%2BD28XjslOqtrs%3D
36. J Elmen M Lindow S Schutz M Lawrence A Petri S Obad, et al. 2008 LNA-mediated microRNA silencing in non-human primates Nature 452 7189 896 899 18368051 10.1038/nature06783 1:CAS:528:DC%2BD1cXkvVSis7w%3D (Pubitemid 351550859)
37. A Petri M Lindow S Kauppinen 2009 MicroRNA silencing in primates: towards development of novel therapeutics Cancer Res 69 2 393 395 19147547 10.1158/0008-5472.CAN-08-2749 1:CAS:528:DC%2BD1MXltV2quw%3D%3D
38. RE Lanford ES Hildebrandt-Eriksen A Petri R Persson M Lindow ME Munk, et al. 2010 Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 5962 198 201 19965718 10.1126/science.1178178 1:CAS:528:DC%2BC3cXht1egsA%3D%3D
39. DA Brown SH Kang SM Gryaznov L DeDionisio O Heidenreich S Sullivan, et al. 1994 Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding J Biol Chem 269 43 26801 26805 7929417 1:CAS:528:DyaK2cXmslClsb0%3D (Pubitemid 24332875)
40. MJ Graham ST Crooke DK Monteith SR Cooper KM Lemonidis KK Stecker, et al. 1998 In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration J Pharmacol Exp Ther 286 1 447 458 9655890 1:CAS:528:DyaK1cXksFCgsL0%3D (Pubitemid 28318021)